A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors.
| Image |  |
|---|---|
| Description | scientific article published on 3 November 2017 |
| Author/s |
author: Vincent A de Weger Jan H M Schellens |
| Publication date | November 3, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |